Insights

Gathering insights about GLP…

Similar companies to GLP

GLP Tech Stack

GLP uses 8 technology products and services including Font Awesome, Floating UI, Pantheon, and more. Explore GLP's tech stack below.

Font Awesome
Font Scripts
Floating UI
Miscellaneous
Pantheon
Platform As A Service
PHP
Programming Languages
Yoast SEO
Search Engines
HSTS
Security
Tailwind CSS
UI Frameworks
Video.js
Video Players

Media & News

Novo Nordisk Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal
Novo has handed Wolff one of the most complex jobs in all of pharmaceuticals.
Dec 19, 2024 | www.barrons.com
Viking Therapeutics: Holiday Gift
Viking Therapeutics has seen a significant drop, losing 50% in value since late October, despite positive news and promising GLP-1 drug developments. The biotech's oral GLP-1 candidate VK2735 showed impressive weight loss results and tolerability, with potential advantages over current weekly injectable treatments. Concerns about manufacturing costs and scalability exist, but Viking's strong pipeline and market potential in obesity make it a compelling investment.
Dec 19, 2024 | seekingalpha.com
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
BALTIMORE--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that it has entered into a collaborative agreement with Renova Health for a planned trial of its TNF-alpha (TNF-α) inhibitor drug isomyosamine (MYMD-1) as a treatment for GLP-1-induced sarcopenia and frailty. The fully funded study is expected to evaluate.
Dec 19, 2024 | www.businesswire.com
Lexaria's Registered GLP-1 Study #4 Begins Dosing
Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss KELOWNA, BC / ACCESSWIRE / December 19, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has begun dosing in the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, (the "Study"). The Study is designed mainly to determine whether Lexaria's proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1 drugs.
Dec 19, 2024 | www.accesswire.com
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative biopharmaceutical company developing novel, ultra long-acting drug implants, today announced that screening and enrollment of the first-in-human clinical trial, known as LIBERATE-1™, has been initiated at two centers in Australia to investigate the safety, tolerability and full pharmacokinetic profile of an exenatide implant. This study is the first clinical application of the Compan.
Dec 19, 2024 | www.businesswire.com
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
Recent sales of a little-known stock, Madrigal Pharmaceuticals NASDAQ: MDGL, could bode well for Novo Nordisk A/S NYSE: NVO. The pharma industry giant has seen explosive sales growth for its GLP-1 agonist drug, semaglutide.
Dec 18, 2024 | www.marketbeat.com
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)
BEIJING and BRIDGEWATER, N.J. , Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18 Injection to conduct a phase 2 clinical trial, a head-to-head with Tirzepatide from Eli Lilly and Company (NYSE: LLY) in the US (NCT06737042).
Dec 18, 2024 | www.prnewswire.com

GLP's Email Address Formats

GLP uses at least 2 format(s):

GLP Email Formats	Example	Percentage
FLast@glprop.com	JDoe@glprop.com	87%
First.Last@glprop.com	John.Doe@glprop.com	3%
LFirst@glprop.com	DJohn@glprop.com	3%
FiLast@glprop.com	JoDoe@glprop.com	2%
FMLast@glprop.com	JMDoe@glprop.com	2%
FirstLast@glprop.com	JohnDoe@glprop.com	1%
FirLast@glprop.com	JohDoe@glprop.com	1%
FMiddleLast@glprop.com	JMichaelDoe@glprop.com	1%
First.Last@glp.com	John.Doe@glp.com	74%
FLast@glp.com	JDoe@glp.com	23%
F.Last@glp.com	J.Doe@glp.com	2%
Last.First@glp.com	Doe.John@glp.com	1%

Frequently Asked Questions

Where is GLP's headquarters located?

GLP's main headquarters is located at 8 Marina View, Asia Square Tower 1 07-04 Singapore, Singapore 018960 SG. The company has employees across 6 continents, including AsiaNorth AmericaSouth America.

What is GLP's phone number?

You can contact GLP's main corporate office by phone at

+1-312-940-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is GLP's stock symbol?

GLP is a publicly traded company; the company's stock symbol is GLP.

What is GLP's official website and social media links?

GLP's official website is glp.com and has social profiles on LinkedIn.

How much revenue does GLP generate?

As of November 2024, GLP's annual revenue reached $750M.

What is GLP's SIC code NAICS code?

GLP's SIC code is 7231 - Beauty Shops NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does GLP have currently?

As of November 2024, GLP has approximately 1K employees across 6 continents, including AsiaNorth AmericaSouth America. Key team members include CFO: A. G. F.Chief Financial Officer - Brasil: D. A.Chief Strategy Officer: H. M.. Explore GLP's employee directory with LeadIQ.

What industry does GLP belong to?

GLP operates in the Real Estate industry.

What technology does GLP use?

GLP's tech stack includes Font AwesomeFloating UIPantheonPHPYoast SEOHSTSTailwind CSSVideo.js.

What is GLP's email format?

GLP's email format typically follows the pattern of . Find more GLP email formats with LeadIQ.

How much funding has GLP raised to date?

As of November 2024, GLP has raised $253M in funding. The last funding round occurred on Jun 06, 2023 for $253M.

When was GLP founded?

GLP was founded in 2009.

GLP

Real EstateSingapore, Singapore1001-5000 Employees

GLP is a leading global business builder, owner, developer and operator of logistics real estate, digital infrastructure, renewable energy and related technologies. GLP’s deep expertise and operational insights allow it to build and scale high-quality businesses and create value for its customers. GLP owns and operates assets and businesses in 17 countries across Asia, Europe and the Americas. GLP Capital Partners is the exclusive investment and asset manager of GLP.

Company Overview

Headquarters: 8 Marina View, Asia Square Tower 1 07-04 Singapore, Singapore 018960 SG
Phone number: +1-312-940-****
Website: glp.com
SIC Code: 7231 - Beauty Shops
Stock Symbol: GLP
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Founded: 2009
Employees: 1001-5000

Media & News

Funding & Financials

$253M
GLP has raised a total of $253M of funding over 1 rounds. Their latest funding round was raised on Jun 06, 2023 in the amount of $253M.
$100M$1B
GLP's revenue is in the range of $100M$1B

Funding & Financials

$253M
GLP has raised a total of $253M of funding over 1 rounds. Their latest funding round was raised on Jun 06, 2023 in the amount of $253M.
$100M$1B
GLP's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to GLP

IPI Partners

Prologis

GLP Tech Stack

Media & News

Novo Nordisk Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal

Viking Therapeutics: Holiday Gift

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)

GLP's Email Address Formats

Frequently Asked Questions

Where is GLP's headquarters located?

What is GLP's phone number?

What is GLP's stock symbol?

What is GLP's official website and social media links?

How much revenue does GLP generate?

What is GLP's SIC code NAICS code?

How many employees does GLP have currently?

What industry does GLP belong to?

What technology does GLP use?

What is GLP's email format?

How much funding has GLP raised to date?

When was GLP founded?

GLP

Company Overview

Media & News

Novo Nordisk Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal

Viking Therapeutics: Holiday Gift

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?